EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Metastasis-directed therapy in oligoprogressive prostate cancer: current evidence and future directions

Jarey H Wang, Daniel Huang, Emmanuel Jnr Amoateng, Asha Tipirneni, Hong Zhang, Kevin Bylund, Michael Cummings, Phuoc T Tran, Matthew P Deek, Philip A Sutera

Annals of Palliative Medicine · 2026-07 · 15 (4) · 64-64

DOI: 10.21037/apm-2026-0041 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Annals of Palliative Medicine, 2026-07. Verfasst von Jarey H Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Prostatic Neoplasms, Castration-Resistant. Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsProstatic Neoplasms, Castration-ResistantHumansMaleNeoplasm MetastasisDisease Progression

Stichwörter der Autor:innen

Castration-resistant prostate cancer (CRPC)castration-sensitive prostate cancer (CSPC)metastasis-directed therapy (MDT)oligoprogressive prostate cancerstereotactic body radiotherapy (SBRT)

Autor:innen und Institutionen

  • Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Department of Radiation Oncology, University of Rochester Medical Center, Rochester, NY, USA.
  • Department of Medicine, Hematology & Oncology, University of Rochester Medical Center, Rochester, NY, USA.
  • Department of Genitourinary Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Department of Radiation Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.

Förderung

  • NCI NIH HHS

Zitieren

APA

Wang, J. H., Huang, D., Amoateng, E. J., Tipirneni, A., Zhang, H., Bylund, K., Cummings, M., Tran, P. T., Deek, M. P., & Sutera, P. A. (2026). Metastasis-directed therapy in oligoprogressive prostate cancer: current evidence and future directions. Annals of Palliative Medicine, 15(4), 64-64. https://doi.org/10.21037/apm-2026-0041

Vancouver

Wang JH, Huang D, Amoateng EJ, Tipirneni A, Zhang H, Bylund K, et al. Metastasis-directed therapy in oligoprogressive prostate cancer: current evidence and future directions. Annals of Palliative Medicine. 2026;15(4):64-64. doi:10.21037/apm-2026-0041

BibTeX
@article{Wang2026,
  author = {Wang, Jarey H and Huang, Daniel and Amoateng, Emmanuel Jnr and Tipirneni, Asha and Zhang, Hong and Bylund, Kevin and Cummings, Michael and Tran, Phuoc T and Deek, Matthew P and Sutera, Philip A},
  title = {Metastasis-directed therapy in oligoprogressive prostate cancer: current evidence and future directions},
  journal = {Annals of Palliative Medicine},
  year = {2026},
  volume = {15},
  number = {4},
  pages = {64--64},
  doi = {10.21037/apm-2026-0041}
}
Kostenlos starten →